Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
May
17
2016
Amgen And Sandoz Do Biosimilar Patent Dance Over Neulasta Foley & Lardner LLP
Jun
30
2020
Federal Circuit Focuses On Active Ingredient, Not Active Moiety, For Scope Of Patent Term Extension Foley & Lardner LLP
Jun
22
2016
Federal Circuit Upholds Same Day Continuation Applications Foley & Lardner LLP
Aug
11
2020
Federal Circuit Finds Significant Contributions For Co-Inventorship Foley & Lardner LLP
Sep
28
2016
Inherent Disclosure Supports Priority Claim: Yeda Research and Development Co. v. Abbott GmbH and Co. Foley & Lardner LLP
Oct
25
2016
Decision To Grant Rehearing En Banc In Apple v. Samsung Foley & Lardner LLP
Dec
20
2016
Fourth Circuit Court Dismisses USPTO December 2015 Holidays Case Foley & Lardner LLP
Jan
10
2017
Federal Circuit Finds IPR Petitioner Lacks Standing To Appeal Foley & Lardner LLP
Feb
14
2017
Federal Circuit Finds "Consisting Of" Requires Reversing Infringement Of Shire Lialda Patent Foley & Lardner LLP
Jun
29
2021
Amendment to China Patent Law Offer PTA, PTE and Patent Linkage Foley & Lardner LLP
Apr
18
2017
Angiomax Patents Limited To Example Foley & Lardner LLP
Aug
1
2017
Federal Circuit Finds Regeneron Transgenic Mouse Patent Invalid For Inequitable Conduct With Intent Inferred From Litigation Misconduct Foley & Lardner LLP
Mar
2
2022
SCOTUS Rules That Faulty Copyright Registrations Based on Mistakes of Law Do Not Invalidate Registrations or Prevent Enforcement Actions Foley & Lardner LLP
Sep
26
2017
USPTO Finds SureGene Personalized Medicine Treatment Unpatentable Under Mayo Foley & Lardner LLP
Mar
11
2015
Federal Circuit Limits Patent Exhaustion Doctrine for Complementary Technology Foley & Lardner LLP
Mar
25
2015
Federal Circuit Finds Disclaimer Based on “Object of Invention” Language Foley & Lardner LLP
May
7
2022
IPR Jeopardy: Estoppel Pitfalls for Multiple Concurrently Filed Petitions Foley & Lardner LLP
May
12
2015
California Supreme Court Scrutinizes Reverse Payment ANDA Settlements Foley & Lardner LLP
Jun
2
2015
Supreme Court on Induced Infringement: Good-Faith Belief of Invalidity Not a Defense and Knowledge of Infringement Required Foley & Lardner LLP
Mar
26
2018
The Public Interest, EPROMs, and Domestic Industry Issues in Component Manufacturer S. 337 Investigations Foley & Lardner LLP
Dec
29
2022
USPTO Delays Fee For Non-DOCX Applications Foley & Lardner LLP
Jun
30
2015
Examination Delay Earns Patent Term Adjustment Only In One Application Foley & Lardner LLP
Jul
14
2015
Contract Manufacturing Makes Angiomax Patents Invalid Under On Sale Bar Foley & Lardner LLP
Jul
16
2015
Attacking Patents on Written Description & Enablement Grounds in Inter Partes Review Foley & Lardner LLP
Mar
15
2023
USPTO Discusses Duty of Disclosure and Duty of Reasonable Inquiry Foley & Lardner LLP
Apr
17
2023
Challenges to IP Protections in Fast-Paced Cloud Environments Foley & Lardner LLP
Aug
20
2015
Federal Circuit Expands Direct Divided Infringement Foley & Lardner LLP
Oct
30
2018
USPTO Access To Relevant Prior Art Initiative Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins